Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Bock

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Vaccine|January 1, 1992
Vaccination against hepatitis A: comparison of different short-term immunization schedulesW Jilg, R Bittner, H L Bock, et al.
Vaccine|January 1, 1992
Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine--a randomized multicentre study with three consecutive vaccine lotsB Kallinowski, K Gmelin, B Kommerell, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1992
The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelersT Weinke, T Loscher, K Fleischer, et al.
Developments in Biological Standardization|January 1, 1997
Factors influencing the analysis of secondary prevention of pertussisC H Wirsing von König, H J Schmitt, H Bogaerts, et al.
European Journal of Pediatrics|June 13, 1998
Factors influencing the spread of pertussis in householdsC H Wirsing von König, S Postels-Multani, H Bogaerts, et al.
The Journal of Pediatrics|April 1, 1997
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of ageH J Schmitt, K Beutel, A Schuind, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|February 4, 2005
Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccineHeng Kock Cheng, V S Rajadurai, Z Amin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 2, 2014
Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantationJ Sasadeusz, H M Prince, A Schwarer, et al.
The Medical Journal of Malaysia|May 13, 2014
Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Cervical Cancer Vaccine in Malaysian Women Aged 18-35 years: A Randomized Controlled TrialB K Lim, K Y Ng, J Omar, et al.
European Journal of Pediatrics|April 16, 1998
Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizationsH J Schmitt, F Zepp, S Müschenborn, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Vaccine|January 1, 1992
Vaccination against hepatitis A: comparison of different short-term immunization schedulesW Jilg, R Bittner, H L Bock, et al.
Vaccine|January 1, 1992
Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine--a randomized multicentre study with three consecutive vaccine lotsB Kallinowski, K Gmelin, B Kommerell, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1992
The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelersT Weinke, T Loscher, K Fleischer, et al.
Developments in Biological Standardization|January 1, 1997
Factors influencing the analysis of secondary prevention of pertussisC H Wirsing von König, H J Schmitt, H Bogaerts, et al.
European Journal of Pediatrics|June 13, 1998
Factors influencing the spread of pertussis in householdsC H Wirsing von König, S Postels-Multani, H Bogaerts, et al.
The Journal of Pediatrics|April 1, 1997
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of ageH J Schmitt, K Beutel, A Schuind, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|February 4, 2005
Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccineHeng Kock Cheng, V S Rajadurai, Z Amin, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 2, 2014
Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantationJ Sasadeusz, H M Prince, A Schwarer, et al.
The Medical Journal of Malaysia|May 13, 2014
Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Cervical Cancer Vaccine in Malaysian Women Aged 18-35 years: A Randomized Controlled TrialB K Lim, K Y Ng, J Omar, et al.
European Journal of Pediatrics|April 16, 1998
Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizationsH J Schmitt, F Zepp, S Müschenborn, et al.
Pageof 7